Double maintains 1 strategies that include CTMX - CytomX Therapeutics, Inc.
Yahoo
The filing is based on late-stage data, which shows that treatment with the subcutaneous version of MRK's Keytruda is at least as effective as the IV version.
Yahoo
The FDA approval is based on late-stage data, which shows that GSK's Blujepa is at least as effective as a leading standard treatment for uncomplicated UTIs.
Yahoo
If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple sclerosis.
Yahoo
If approved, SNY's tolebrutinib will be the first therapy to target smoldering neuroinflammation, a key driver of disability accumulation in multiple sclerosis.
Yahoo
ELEV decides to stop developing its lead drug after disappointing data from an early-stage study evaluating its sole clinical-stage drug in gastric cancers.
Yahoo
AKBA's shares fell after announcing the pricing of its secondary issue of shares, which were at a discount to the previous closing price.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SRDX | 63.87% | $436.46M | +9.43% | 0.00% |
TRTX | 49.49% | $660.18M | +4.62% | 11.77% |
RCKY | 49.49% | $129.62M | -36.63% | 3.62% |
ATEN | 48.94% | $1.21B | +19.44% | 1.47% |
TECH | 46.14% | $9.27B | -15.53% | 0.55% |
FLG | 45.57% | $4.82B | +20.66% | 0.35% |
PINS | 43.09% | $21.03B | -12.23% | 0.00% |
AMCR | 40.60% | $14.02B | +2.65% | 5.18% |
RWT | 40.24% | $806.47M | -3.50% | 11.38% |
TRN | 37.83% | $2.30B | +3.12% | 4.08% |
STGW | 37.79% | $695.84M | +1.68% | 0.00% |
OSW | 37.54% | $1.76B | +25.30% | 0.72% |
LC | 37.22% | $1.17B | +17.81% | 0.00% |
GRMN | 36.66% | $41.78B | +47.35% | 1.39% |
XNCR | 36.26% | $749.71M | -51.46% | 0.00% |
TMDX | 35.93% | $2.26B | -8.38% | 0.00% |
DD | 35.48% | $31.22B | -3.26% | 2.08% |
LIVN | 35.46% | $2.13B | -28.79% | 0.00% |
AXTA | 33.64% | $7.24B | -3.58% | 0.00% |
VRSK | 33.62% | $41.75B | +27.85% | 0.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPA | 37.23% | $290.25M | 0% |
CPRJ | 36.82% | $48.46M | 0.69% |
QQA | 31.30% | $172.66M | 0% |
PBE | 27.01% | $233.11M | 0.58% |
XBI | 25.36% | $5.33B | 0.35% |
BSJP | 23.26% | $993.50M | 0.43% |
CPNJ | 21.98% | $29.51M | 0.69% |
ETH | 21.94% | $1.29B | 0% |
IBB | 21.87% | $5.92B | 0.45% |
ETHW | 21.06% | $178.48M | 0% |
EZET | 21.05% | $22.10M | 0% |
ETHA | 20.92% | $2.24B | 0.25% |
CETH | 20.63% | $8.63M | 0% |
FETH | 20.57% | $744.15M | 0.25% |
QETH | 20.48% | $14.08M | 0.25% |
PTBD | 20.48% | $157.87M | 0.6% |
ETHV | 20.44% | $86.59M | 0% |
NUHY | 19.84% | $99.32M | 0.31% |
EFAA | 19.67% | $100.51M | 0% |
HYS | 19.28% | $1.49B | 0.56% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LEG | -46.10% | $1.07B | -58.15% | 2.53% |
ASTE | -40.24% | $786.61M | -19.38% | 1.53% |
SBUX | -38.41% | $111.42B | +7.17% | 2.42% |
CVS | -36.92% | $85.42B | -14.84% | 3.92% |
CDW | -33.31% | $21.23B | -36.67% | 1.55% |
GPN | -31.86% | $24.08B | -24.76% | 1.02% |
CLBK | -30.13% | $1.57B | -11.30% | 0.00% |
OI | -29.03% | $1.77B | -31.56% | 0.00% |
CVRX | -27.02% | $318.42M | -31.94% | 0.00% |
EL | -26.24% | $23.74B | -56.59% | 3.02% |
NCLH | -25.95% | $8.34B | -9.46% | 0.00% |
DBRG | -25.82% | $1.54B | -54.44% | 0.45% |
SWKS | -25.72% | $10.39B | -39.62% | 4.32% |
GIC | -25.09% | $858.17M | -49.03% | 4.50% |
CLX | -25.07% | $18.14B | -2.90% | 3.29% |
AGS | -24.12% | $499.64M | +33.81% | 0.00% |
KHC | -23.62% | $36.36B | -17.89% | 5.22% |
HI | -22.81% | $1.70B | -51.18% | 3.73% |
CCCS | -20.86% | $5.94B | -23.47% | 0.00% |
RYI | -20.17% | $731.30M | -31.42% | 3.30% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBA | -19.41% | $822.16M | 0.93% |
CNBS | -16.67% | $67.47M | 0.77% |
MSOS | -16.17% | $354.63M | 0.83% |
USCI | -15.88% | $236.09M | 1.07% |
UGA | -15.80% | $88.11M | 0.97% |
YOLO | -15.46% | $23.28M | 1.03% |
COMT | -14.96% | $674.22M | 0.48% |
GCC | -14.50% | $148.21M | 0.55% |
DBE | -14.02% | $54.58M | 0.77% |
GSG | -13.97% | $1.04B | 0.75% |
USL | -13.85% | $46.60M | 0.85% |
FTGC | -13.84% | $2.50B | 1.02% |
OILK | -13.48% | $66.42M | 0.69% |
BNO | -13.29% | $95.40M | 1% |
USO | -12.99% | $1.02B | 0.6% |
PDBC | -12.54% | $4.82B | 0.59% |
CLOZ | -12.25% | $817.63M | 0.5% |
DBO | -12.02% | $197.54M | 0.77% |
DBC | -11.49% | $1.32B | 0.87% |
AMDY | -10.26% | $144.38M | 1.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPHD | 0.02% | $241.87M | 0.52% |
RSPT | 0.03% | $3.08B | 0.4% |
WIP | -0.05% | $317.87M | 0.5% |
INFL | 0.05% | $1.13B | 0.85% |
IVLU | 0.06% | $2.01B | 0.3% |
HDV | 0.10% | $11.29B | 0.08% |
CNYA | 0.10% | $219.11M | 0.6% |
DBEU | -0.11% | $660.46M | 0.45% |
DMXF | -0.12% | $752.72M | 0.12% |
FGD | -0.13% | $594.99M | 0.56% |
PMAY | 0.15% | $497.84M | 0.79% |
IJAN | -0.15% | $185.31M | 0.85% |
HDEF | -0.16% | $1.85B | 0.09% |
MILN | -0.17% | $113.49M | 0.5% |
EZU | 0.17% | $8.83B | 0.51% |
FTRI | 0.18% | $91.12M | 0.7% |
SNSR | -0.21% | $205.85M | 0.68% |
EWQ | -0.21% | $484.51M | 0.5% |
PAWZ | 0.24% | $56.12M | 0.5% |
IMOM | 0.24% | $89.13M | 0.39% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
INVH | -0.01% | $21.35B | -0.63% | 3.27% |
VTS | 0.01% | $948.64M | +5.40% | 8.67% |
ACMR | 0.01% | $1.47B | -23.02% | 0.00% |
NEM | 0.01% | $54.42B | +32.53% | 2.05% |
HRMY | 0.01% | $1.90B | +0.55% | 0.00% |
HLF | 0.02% | $873.33M | -5.27% | 0.00% |
FET | 0.02% | $247.43M | +2.81% | 0.00% |
TKR | 0.02% | $5.04B | -18.19% | 1.98% |
CRDF | 0.02% | $208.89M | -45.20% | 0.00% |
GNTX | 0.03% | $5.29B | -35.53% | 2.06% |
PSEC | 0.03% | - | - | 15.79% |
OMI | -0.04% | $697.54M | -67.18% | 0.00% |
JBTM | -0.04% | $6.34B | +20.49% | 0.33% |
TSE | -0.04% | $130.57M | -3.66% | 1.09% |
LUV | -0.04% | $19.90B | +15.08% | 2.19% |
ARW | 0.04% | $5.39B | -19.53% | 0.00% |
AMRC | 0.04% | $634.70M | -51.66% | 0.00% |
IIIV | 0.04% | $577.98M | +9.40% | 0.00% |
Z | -0.04% | $16.63B | +42.18% | 0.00% |
XRX | 0.04% | $605.11M | -72.87% | 18.42% |
Current Value
$0.651 Year Return
Current Value
$0.651 Year Return